A client with myasthenia gravis on scheduled pyridostigmine … | MyMerci
NCLEX-RN PA
Question

A client with myasthenia gravis on scheduled pyridostigmine reports increasing weakness, abdominal cramping, excessive salivation, and lacrimation 45 minutes after the last dose. Which assessment finding most strongly supports cholinergic crisis rather than myasthenic crisis?

Explanation
Cholinergic crisis results from acetylcholinesterase-inhibitor overdose. Muscarinic excess produces SLUDGE (salivation, lacrimation, urination, defecation, GI cramping, emesis) with miosis and bradycardia, typically within 30-60 minutes of a dose. Myasthenic crisis (under-medication) presents with worsening weakness HOURS after a dose and improves with edrophonium. Stress can trigger either crisis and is non-specific.

In-depth explanation

Distinguishing feature: timing (within 1 hour vs hours later) plus muscarinic SLUDGE pattern. Atropine reverses muscarinic effects in cholinergic crisis; pyridostigmine is HELD.

Clinical scenario

Hospitalized with worsening dysphagia. Pyridostigmine 60 mg PO every 4 hours. Pupils 2 mm bilaterally, HR 54, BP 102/64.

Key concepts

Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.